Swiss drug major Novartis (NVS) reported Tuesday that its third-quarter net income climbed 43 percent to $2.76 billion from last year's $1.93 billion. Earnings per share were $1.23, up 45 percent from $0.85 a year ago.
Core net income was $3.83 billion or $1.71 per share, compared to $3.47 billion or $1.52 per share last year.
On average, five analysts polled by Thomson Reuters expected earnings of $1.65 per share for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.